Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

被引：185

作者：

Huang, Chen ^{[1
,2
]}

Chen, Lijun ^{[3
]}

Savage, Sara R. ^{[1
,2
]}

Eguez, Rodrigo Vargas ^{[3
]}

Dou, Yongchao ^{[1
,2
]}

Li, Yize ^{[4
,5
]}

Leprevost, Felipe da Veiga ^{[6
]}

Jaehnig, Eric J. ^{[1
,2
]}

Lei, Jonathan T. ^{[1
,2
]}

Wen, Bo ^{[1
,2
]}

Schnaubelt, Michael ^{[3
]}

Krug, Karsten ^{[7
]}

Song, Xiaoyu ^{[8
,9
]}

Cieslik, Marcin ^{[6
,10
,11
]}

Chang, Hui-Yin ^{[6
]}

Wyczalkowski, Matthew A. ^{[4
,5
]}

Li, Kai ^{[1
,2
]}

Colaprico, Antonio ^{[12
,13
]}

Li, Qing Kay ^{[3
]}

Clark, David J. ^{[3
]}

Hu, Yingwei ^{[3
]}

Cao, Liwei ^{[3
]}

Pan, Jianbo ^{[3
,14
]}

Wang, Yuefan ^{[3
]}

Cho, Kyung-Cho ^{[3
]}

Shi, Zhiao ^{[1
,2
]}

Liao, Yuxing ^{[1
,2
]}

Jiang, Wen ^{[1
,2
]}

Anurag, Meenakshi ^{[1
]}

Ji, Jiayi ^{[8
,9
]}

Yoo, Seungyeul ^{[15
,16
]}

Zhou, Daniel Cui ^{[4
,5
]}

Liang, Wen-Wei ^{[4
,5
]}

Wendl, Michael ^{[4
,5
]}

Vats, Pankaj ^{[11
]}

Carr, Steven A. ^{[7
]}

Mani, D. R. ^{[7
]}

Zhang, Zhen ^{[3
]}

Qian, Jiang ^{[14
]}

Chen, Xi S. ^{[12
,13
]}

Pico, Alexander R. ^{[17
]}

Wang, Pei ^{[15
,16
]}

Chinnaiyan, Arul M. ^{[6
,10
,11
]}

Ketchum, Karen A. ^{[18
]}

Kinsinger, Christopher R. ^{[19
]}

Robles, Ana, I ^{[19
]}

An, Eunkyung ^{[19
]}

Hiltke, Tara ^{[19
]}

Mesri, Mehdi ^{[19
]}

Thiagarajan, Mathangi ^{[20
]}

机构：

[1] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA

[2] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA

[3] Johns Hopkins Univ, Dept Pathol & Oncol, Baltimore, MD 21231 USA

[4] Washington Univ, Dept Med, St Louis, MO 63110 USA

[5] Washington Univ, McDonnell Genome Inst, St Louis, MO 63108 USA

[6] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA

[7] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA

[8] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[9] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA

[10] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA

[11] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA

[12] Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL 33136 USA

[13] Univ Miami, Div Biostat, Dept Publ Hlth Sci, Miller Sch Med, Miami, FL 33136 USA

[14] Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD 21231 USA

[15] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA

[16] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA

[17] Gladstone Inst, Inst Data Sci & Biotechnol, San Francisco, CA 94158 USA

[18] ESAC Inc, Rockville, MD 20850 USA

[19] NCI, Off Canc Clin Prote Res, Bethesda, MD 20892 USA

[20] Frederick NaVonal Lab Canc Res, Leidos Biomed Res Inc, Frederick, MD 21702 USA

[21] Vanderbilt Univ, Dept Cell & Dev Biol, Sch Med, Nashville, TN 37232 USA

[22] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA

[23] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, PL-71252 Szczecin, Poland

[24] Int Inst Mol Oncol, PL-60203 Poznan, Poland

[25] Poznan Univ Med Sci, PL-61701 Poznan, Poland

[26] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland

[27] Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Boston, MA 02114 USA

[28] MD Anderson Canc Ctr, Dept Pathol, Div Pathol & Lab Med, Houston, TX 77030 USA

来源：

CANCER CELL | 2021年 / 39卷 / 03期

关键词：

PLATINUM-BASED CHEMOTHERAPY; PATIENT-DERIVED XENOGRAFTS; FACTOR RECEPTOR ANTIBODY; COPY NUMBER ALTERATION; PHASE-II MULTICENTER; FALSE DISCOVERY RATE; RNA-SEQ DATA; READ ALIGNMENT; OPEN-LABEL; STATISTICAL-MODEL;

D O I：

10.1016/j.ccell.2020.12.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We present a proteogenomic study of 108 human papilloma virus (HPV)-negative head and neck squamous cell carcinomas (HNSCCs). Proteomic analysis systematically catalogs HNSCC-associated proteins and phospho-sites, prioritizes copy number drivers, and highlights an oncogenic role for RNA processing genes. Proteomic investigation of mutual exclusivity between FAT1 truncating mutations and 11q13.3 amplifications reveals dys-regulated actin dynamics as a common functional consequence. Phosphoproteomics characterizes two modes of EGFR activation, suggesting a new strategy to stratify HNSCCs based on EGFR ligand abundance for effective treatment with inhibitory EGFR monoclonal antibodies. Widespread deletion of immune modulatory genes accounts for low immune infiltration in immune-cold tumors, whereas concordant upregulation of multiple immune checkpoint proteins may underlie resistance to anti-programmed cell death protein 1 mono-therapy in immune-hot tumors. Multi-omic analysis identifies three molecular subtypes with high potential for treatment with CDK inhibitors, anti-EGFR antibody therapy, and immunotherapy, respectively. Altogether, pro-teogenomics provides a systematic framework to inform HNSCC biology and treatment.

引用

页码：361 / +

页数：35

共 50 条

[21] Treatment of Recurrent and Metastatic HPV-Associated Squamous Cell Carcinoma
Wotman, Michael
Gold, Brandon
Takahashi, Mai
Draper, Lindsey
Posner, Marshall
CURRENT OTORHINOLARYNGOLOGY REPORTS, 2022, 10 (02) : 208 - 217
[22] Immunotherapy for squamous cell carcinoma of the head and neck
Yokota, Tomoya
Homma, Akihiro
Kiyota, Naomi
Tahara, Makoto
Hanai, Nobuhiro
Asakage, Takahiro
Matsuura, Kazuto
Ogawa, Takenori
Saito, Yuki
Sano, Daisuke
Kodaira, Takeshi
Motegi, Atsushi
Yasuda, Koichi
Takahashi, Shunji
Tanaka, Kaoru
Onoe, Takuma
Okano, Susumu
Imamura, Yoshinori
Ariizumi, Yosuke
Hayashi, Ryuichi
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (10) : 1089 - 1096
[23] Afatinib in squamous cell carcinoma of the head and neck
Specenier, Pol
Vermorken, Jan
EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
[24] Pharmacotherapy of head and neck squamous cell carcinoma
Pan, Quintin
Gorin, Michael A.
Teknos, Theodoros N.
EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (14) : 2291 - 2302
[25] Epidermal Growth Factor Receptor Inhibition in Squamous Cell Carcinoma of the Head and Neck
Machiels, Jean-Pascal
Schmitz, Sandra
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (06) : 1011 - +
[26] Evasion of apoptosis and treatment resistance in squamous cell carcinoma of the head and neck
O'Leary, Ben
Skinner, Heath
Schoenfeld, Jonathan
Licitra, Lisa
Le Tourneau, Christophe
Esdar, Christina
Schroeder, Andreas
Salmio, Satu
Psyrri, Amanda
CANCER TREATMENT REVIEWS, 2024, 129
[27] Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma
Tang, Eliane
Lahmi, Lucien
Meillan, Nicolas
Pietta, Gianandrea
Albert, Sebastien
Maingon, Philippe
CURRENT ONCOLOGY REPORTS, 2019, 21 (11)
[28] Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy
Li, Hong-Xia
Gong, Yu-Wen
Yan, Pi-Jun
Xu, Yong
Qin, Gang
Wen, Wei-Ping
Teng, Fang-Yuan
FRONTIERS IN IMMUNOLOGY, 2024, 15
[29] Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Sacco, Assuntina G.
Cohen, Ezra E.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29) : 3305 - +
[30] Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Borel, Christian
Jung, Alain C.
Burgy, Mickael
CANCERS, 2020, 12 (09) : 1 - 19

← 1 2 3 4 5 →